logo-loader

Wound Management Technologies, Inc

Receive alerts
Market:
OTCMKTS
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

Wound Management Technologies, Inc. is an emerging commercial stage company with its primary products in the $5B worldwide advanced wound care market. Wound Management’s primary focus is the distribution of its unique, patented collagen product, CellerateRX®, which is FDA cleared and reimbursable under Medicare Part B. Wound Management has other advanced biotech products in development including a patented resorbable bone wax line that is in late stages of development, as well as a subsidiary focused on technology for secure healthcare data collaboration and storage.